Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countries

This publication has 19 references indexed in Scilit:

• Tigecycline: A New Glycylcycline for Treatment of Serious Infections
  Clinical Infectious Diseases, 2005
• In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)
  Diagnostic Microbiology and Infectious Disease, 2005
• Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia
  Diagnostic Microbiology and Infectious Disease, 2005
• Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcusaureus recovered from nosocomial and community-acquired infections
  International Journal of Antimicrobial Agents, 2004
• In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections
  Diagnostic Microbiology and Infectious Disease, 2004
• In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain
  Antimicrobial Agents and Chemotherapy, 2002
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
  Clinical Microbiology Reviews, 2001
• Carriage of Antibiotic-Resistant Pneumococci among Asian Children: A Multinational Surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP)
  Clinical Infectious Diseases, 2001
• Comparative In Vitro Activities of GAR-936 against Aerobic and Anaerobic Animal and Human Bite Wound Pathogens
  Antimicrobial Agents and Chemotherapy, 2000
• Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates
  Diagnostic Microbiology and Infectious Disease, 2000